Last reviewed · How we verify

mRNA — Competitive Intelligence Brief

mRNA (mRNA) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: mRNA therapeutic. Area: Oncology, Immunology, Infectious Disease, Genetic Disorders.

marketed mRNA therapeutic Oncology, Immunology, Infectious Disease, Genetic Disorders Biologic Live · refreshed every 30 min

Target snapshot

mRNA (mRNA) — University Hospital Tuebingen. mRNA-based therapeutics deliver genetic instructions to cells to produce therapeutic proteins or trigger immune responses.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
mRNA TARGET mRNA University Hospital Tuebingen marketed mRNA therapeutic
mRNA-1083 mRNA-1083 ModernaTX, Inc. phase 3 mRNA therapeutic myostatin

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (mRNA therapeutic class)

  1. ModernaTX, Inc. · 1 drug in this class
  2. University Hospital Tuebingen · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). mRNA — Competitive Intelligence Brief. https://druglandscape.com/ci/mrna. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: